148 related articles for article (PubMed ID: 12658964)
1. [Concepts in studying cost effectiveness of pediatric asthma treatment in Germany, Switzerland and Austria].
Frischer T; Sennhauser FH; Fischer JE; Szucs T; Köck C
Wien Med Wochenschr; 2003; 153(3-4):59-64. PubMed ID: 12658964
[TBL] [Abstract][Full Text] [Related]
2. [Cost effectiveness of treatment with salmeterol/fluticasone compared to montelukast for the control of persistent asthma in children].
Rely K; McQuire SE; Alexandre PK; Escudero GS
Value Health; 2011; 14(5 Suppl 1):S43-7. PubMed ID: 21839898
[TBL] [Abstract][Full Text] [Related]
3. [Medication adherence in asthma therapy--a structured review].
Fischer J; Wimmer A; Mahlich J
Pneumologie; 2013 Jul; 67(7):406-14. PubMed ID: 23797492
[TBL] [Abstract][Full Text] [Related]
4. Financing in knee arthroplasty: a benchmarking analysis.
Effenberger H; Rehart S; Zumstein MD; Schuh A
Arch Orthop Trauma Surg; 2008 Dec; 128(12):1349-56. PubMed ID: 18309508
[TBL] [Abstract][Full Text] [Related]
5. A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II).
Sullivan SD; Lee TA; Blough DK; Finkelstein JA; Lozano P; Inui TS; Fuhlbrigge AL; Carey VJ; Wagner E; Weiss KB
Arch Pediatr Adolesc Med; 2005 May; 159(5):428-34. PubMed ID: 15867115
[TBL] [Abstract][Full Text] [Related]
6. Development of an economic model to assess the cost effectiveness of asthma management strategies.
Price MJ; Briggs AH
Pharmacoeconomics; 2002; 20(3):183-94. PubMed ID: 11929348
[TBL] [Abstract][Full Text] [Related]
7. A cost-effectiveness analysis of first-line controller therapies for persistent asthma.
Shih YC; Mauskopf J; Borker R
Pharmacoeconomics; 2007; 25(7):577-90. PubMed ID: 17610338
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of asthma therapy: a comprehensive review.
Domínguez-Ortega J; Phillips-Anglés E; Barranco P; Quirce S
J Asthma; 2015; 52(6):529-37. PubMed ID: 25539023
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of fluticasone propionate administered via metered-dose inhaler plus babyhaler spacer in the treatment of asthma in preschool-aged children.
Bisgaard H; Price MJ; Maden C; Olsen NA
Chest; 2001 Dec; 120(6):1835-42. PubMed ID: 11742910
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomics of asthma treatment.
Cleland J; Thomas M; Price D
Expert Opin Pharmacother; 2003 Mar; 4(3):311-8. PubMed ID: 12614183
[TBL] [Abstract][Full Text] [Related]
11. Asthma treatment guidelines: how do we measure up?
Navarro RP
Am J Manag Care; 2005 Nov; 11(14 Suppl):S422-6; quiz S427-33. PubMed ID: 16300463
[TBL] [Abstract][Full Text] [Related]
12. A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients.
Manfrin A; Tinelli M; Thomas T; Krska J
BMC Health Serv Res; 2017 Apr; 17(1):300. PubMed ID: 28438152
[TBL] [Abstract][Full Text] [Related]
13. [Cost of asthma therapy in relation to severity. An empirical study].
Graf von der Schulenburg JM; Greiner W; Molitor S; Kielhorn A
Med Klin (Munich); 1996 Oct; 91(10):670-6. PubMed ID: 9019647
[TBL] [Abstract][Full Text] [Related]
14. [Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany].
Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
Z Rheumatol; 2004 Feb; 63(1):59-75. PubMed ID: 14991279
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma.
Zafari Z; Sadatsafavi M; Marra CA; Chen W; FitzGerald JM
PLoS One; 2016; 11(1):e0146003. PubMed ID: 26751790
[TBL] [Abstract][Full Text] [Related]
16. Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: a simulation study.
Zafari Z; Lynd LD; FitzGerald JM; Sadatsafavi M
J Allergy Clin Immunol; 2014 Oct; 134(4):908-915.e3. PubMed ID: 24875619
[TBL] [Abstract][Full Text] [Related]
17. Measuring costs and consequences in economic evaluation in asthma.
Sculpher MJ; Price M
Respir Med; 2003 May; 97(5):508-20. PubMed ID: 12735668
[TBL] [Abstract][Full Text] [Related]
18. [Direct cost of medical treatment to the asthmatic patient in the pediatric emergency service of a medical care tier-two hospital].
Ceballos Martínez ZI; González Mercado E; Jiménez Grandes I; Peralta Bahena ME; Tah Arias WF
Rev Alerg Mex; 2003; 50(2):43-7. PubMed ID: 12825487
[TBL] [Abstract][Full Text] [Related]
19. The Cost of Asthma Treatment in Phramongkutlao Hospital: Population-Based Study in Adults.
Boonpiyathad T; Yimsawad S; Sangasapaviriya A
J Med Assoc Thai; 2016 Jan; 99(1):51-7. PubMed ID: 27455824
[TBL] [Abstract][Full Text] [Related]
20. Asthma Cost-Effectiveness Analyses: Are We Using the Recommended Outcomes in Estimating Value?
Kim CH; Dilokthornsakul P; Campbell JD; van Boven JFM
J Allergy Clin Immunol Pract; 2018; 6(2):619-632. PubMed ID: 28967548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
